Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
BACKGROUND
Perceived burden of colorectal cancer (CRC) screening is an important determinant of participation in subsequent screening rounds and therefore crucial for the effectiveness of a screening programme. This study determined differences in perceived burden and willingness to return for a second screening round among participants of a randomised population-based trial comparing a guaiac-based faecal occult blood test (gFOBT), a faecal immunochemical test (FIT) and flexible sigmoidoscopy (FS) screening.


METHODS
A representative sample of the Dutch population (aged 50-74years) was randomised to be invited for gFOBT, FIT and FS screening. A random sample of participants of each group was asked to complete a questionnaire about test burden and willingness to return for CRC screening.


RESULTS
In total 402/481 (84%) gFOBT, 530/659 (80%) FIT and 852/1124 (76%) FS screenees returned the questionnaire. The test was reported as burdensome by 2.5% of gFOBT, 1.4% of FIT and 12.9% of FS screenees (comparing gFOBT versus FIT p=0.05; versus FS p<0.001). In total 94.1% of gFOBT, 94.0% of FIT and 83.8% of FS screenees were willing to attend successive screening rounds (comparing gFOBT versus FIT p=0.84; versus FS p<0.001). Women reported more burden during FS screening than men (18.2% versus 7.7%; p<0.001).


CONCLUSIONS
FIT slightly outperforms gFOBT with a lower level of reported discomfort and overall burden. Both FOBTs are better accepted than FS screening. All three tests have a high level of acceptance, which may affect uptake of subsequent screening rounds and should be taken into consideration before implementing a CRC screening programme.
Hol
L
L
Department of Gastroenterology and Hepatology, Erasmus University Medical Centre, Rotterdam, The Netherlands. l.hol.1@erasmusmc.nl
de Jonge
V
V
van Leerdam
M E
ME
van Ballegooijen
M
M
Looman
C W N
CW
van Vuuren
A J
AJ
Reijerink
J C I Y
JC
Habbema
J D F
JD
Essink-Bot
M L
ML
Kuipers
E J
EJ
D000368:Aged; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000523:psychology; D017281:Cost of Illness; D055088:Early Detection of Cancer / Q000379:methods / Q000523:psychology*; D005260:Female; D006138:Guaiac; D006801:Humans; D007159:Immunologic Tests / Q000379:methods; D007202:Indicators and Reagents; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D009780:Occult Blood; D010146:Pain / Q000209:etiology; D017060:Patient Satisfaction; D012752:Shame; D012812:Sigmoidoscopy / Q000379:methods / Q000523:psychology
D007202:Indicators and Reagents; D006138:Guaiac